DSM to complete divestment program through sale of DSM Elastomers
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has reached an agreement regarding the sale of the remaining part of DSM Elastomers (DSM Elastomers) to LANXESS for 310 million on a cash and debt-free basis. The intended sale is expected to close in the first months of 2011, subject to regulatory and other customary approvals and notifications.